Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period.
about
Very Late Stent Thrombosis 11 Years after Implantation of a Drug-Eluting StentStent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014Optimal Duration of Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: Shorter or Longer?Outcomes of ≤6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation: A meta-analysis and meta-regression.Adherence to dual antiplatelet therapy after coronary stenting: a systematic review.Cost effectiveness of drug-eluting stents in acute myocardial infarction patients in Germany: results from administrative data using a propensity score-matching approach.Dual antiplatelet therapy over 6 months increases the risk of bleeding after biodegradable polymer-coated sirolimus eluting stents implantation: insights from the CREATE studyAnother view of personalized medicine: optimizing stent selection on the basis of predicted benefit in percutaneous coronary intervention.Antiplatelet therapy discontinuation and the risk of serious cardiovascular events after coronary stenting: observations from the CREDO-Kyoto Registry Cohort-2.Clopidogrel use and early outcomes among older patients receiving a drug-eluting coronary artery stentHistopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortiumRisks and Benefits of Dual Antiplatelet Therapy Beyond 12 Months After Coronary Stenting: A Prospective Randomized Cohort StudySafety of temporary and permanent suspension of antiplatelet therapy after drug eluting stent implantation in contemporary "real-world" practiceThe fibronectin synergy site re-enforces cell adhesion and mediates a crosstalk between integrin classes.Long-term outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents.Benefits of and safety concerns associated with drug-eluting coronary stents.Shock wave lithotripsy in patients requiring anticoagulation or antiplatelet agents.Very Late Stent Thrombosis of Sirolimus-eluting Stent 59 Months After Implantation: A First Report from The Middle-East and Review of Literature.Percutaneous revascularization of left main: role of imaging, techniques, and adjunct pharmacology.Management of antiplatelet therapy inpatients at risk for coronary StentThrombosis undergoing non-cardiac surgery.Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent implantation: a review of the current guidelines and literature.2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and InterventiAtrial fibrillation, stroke, and quality of life.Late stent thrombosis: the last remaining obstacle in coronary interventional therapy.Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials.Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation.Discontinuation of dual antiplatelet therapy over 12 months after acute coronary syndromes increases risk for adverse events in patients treated with percutaneous coronary intervention: systematic review and meta-analysis.Dual antiplatelet therapy in the anticoagulated patient undergoing percutaneous coronary intervention risks, benefits, and unanswered questions.Management of antithrombotic therapy in patients undergoing electrophysiological device surgery.Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation.Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis: A Report of the PRESTIGE Consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort).Drug eluting stents: To evolve or dissolve?The comparative safety of bare-metal and drug-eluting intracoronary stents.One-year clinical outcomes after sirolimus-eluting coronary stent implantation for acute myocardial infarction in the worldwide e-SELECT registry.Effectiveness of prolonged clopidogrel-based dual antiplatelet therapy after drug-eluting stent implantation: Evidence-based meta-analysis.Prolonged dual antiplatelet therapy after drug-eluting stenting: meta-analysis of randomized trials.Stent thrombosis and optimal duration of dual antiplatelet therapy after coronary stenting in contemporary practice.Stent thrombosis: incidence, predictors and new technologiesThe role of intracoronary imaging in acute coronary syndromes: OCT in focus.Clustering of acute and subacute stent thrombosis related to the introduction of generic clopidogrel.
P2860
Q26778663-82DA9CD1-8D4E-4604-AC23-D4CA37BFDEE2Q26785321-D174C8A0-E9CD-4CFC-9159-2A29ACB2F00CQ26852812-D349E97E-1C84-4256-AE9B-ACE9D960D49BQ30239889-FD7CF975-2C4C-45D2-92CF-B66A6F86F85DQ34076164-19DB9D75-FE6A-4BB5-9ED4-8D23E67ED73EQ34265103-71A20856-4A99-41CB-AF7A-4F69B9F56411Q34531925-B597A4AA-AE73-46AA-8BA5-CDF6EE0E972FQ35101374-4D5D3B40-1DF2-4EE5-A7F7-971434332727Q35324208-CEBBA464-7414-444D-B803-113AEED60AD7Q35680854-23D65D2D-31A5-47A5-8A3D-CA48E99A8E41Q36915078-E281886D-7F90-45C4-8B53-4E709B70AB02Q36988677-F1DE6A11-211D-4633-817C-EE9BEB00E21BQ37134004-1F599FE5-A28A-40D1-9789-AE4ED28FCD71Q37613896-58BE736A-0CA9-4252-BA8F-65F0BDEFF3CDQ37685137-AD85704D-645E-4074-A521-F71AEF02BB64Q37707419-9F28A68F-9D63-47B2-AF9C-9AE83E3D2D7DQ37862388-6E13BAA0-CF83-4D7A-8B17-33B2C180964BQ37897983-946619ED-8895-4A6F-B599-ABF56D284A5BQ37909255-20B385E5-B73B-4CF9-8C37-479878FCF515Q37937717-2633E39C-90DB-424D-B67F-39BF71C45969Q37953153-BAF11C1D-5F93-4511-985F-ED65F14D507DQ37953885-DDA5F4EC-E3F6-4381-81DB-76452708746BQ38006746-523FBEE4-D7C7-4D9B-8515-D09872F28CCEQ38023285-B479A175-162A-49DF-B89B-FC40C532EBCCQ38054689-09FE2416-4B8A-450D-B293-9B5AD37FE140Q38063290-1ACA1143-6D13-40D3-9557-0A3BC69910B7Q38195850-CAB24B1E-758F-4526-9BF1-02CA8AF61225Q38261199-70E3E538-83D0-47BB-87EC-E3067E2A6264Q38364982-DB2DCC7B-688A-4FCB-8775-54D039E26AD5Q38436521-996451E4-B9FB-4D17-8D38-E0E625220D02Q38673193-681B57D3-F1F4-4613-885D-8158F59C32FBQ39008645-CED27706-5118-4DFF-84BC-82DA7E470517Q39840291-D417CF46-A649-4F53-B1FB-CA73C26D39CCQ40022292-08C0F9D8-D98E-4DF8-873F-FC3D4CB7F224Q41016271-6F1BEA77-EE43-420C-8EDC-DC1FBE20B77FQ41028031-1D537BBA-6660-4408-AB88-75EEA8A3C155Q41607661-4C1198C0-B2F5-4AE7-AAC2-989EF7B73018Q41962888-5592F823-0FC9-40F1-B1FB-3966E7E44F1AQ42287703-5365CB23-C23D-4BE6-9C19-191189CC00E9Q43911948-8FD60193-FAEA-4363-87B1-C992C51796FE
P2860
Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Stent thrombosis after drug-el ...... therapy over a 4-year period.
@en
Stent thrombosis after drug-el ...... therapy over a 4-year period.
@nl
type
label
Stent thrombosis after drug-el ...... therapy over a 4-year period.
@en
Stent thrombosis after drug-el ...... therapy over a 4-year period.
@nl
prefLabel
Stent thrombosis after drug-el ...... therapy over a 4-year period.
@en
Stent thrombosis after drug-el ...... therapy over a 4-year period.
@nl
P2093
P2860
P50
P356
P1476
Stent thrombosis after drug-el ...... therapy over a 4-year period.
@en
P2093
Julia Ellert
Julia Goedel
Olga Bruskina
Steffen Massberg
Tibor Schuster
P2860
P304
P356
10.1093/EURHEARTJ/EHP275
P577
2009-07-11T00:00:00Z